TRICOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tricor, and when can generic versions of Tricor launch?
Tricor is a drug marketed by Abbvie and is included in three NDAs.
The generic ingredient in TRICOR is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tricor
A generic version of TRICOR was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRICOR?
- What are the global sales for TRICOR?
- What is Average Wholesale Price for TRICOR?
Summary for TRICOR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRICOR |
Paragraph IV (Patent) Challenges for TRICOR
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| TRICOR | Tablets | fenofibrate | 48 mg | 021656 | 1 | 2008-07-01 |
| TRICOR | Tablets | fenofibrate | 145 mg | 021656 | 1 | 2007-10-19 |
US Patents and Regulatory Information for TRICOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-004 | Jun 30, 1999 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021203-003 | Sep 4, 2001 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021203-001 | Sep 4, 2001 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-003 | Jun 30, 1999 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-002 | Feb 9, 1998 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TRICOR
See the table below for patents covering TRICOR around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 83374 | ⤷ Start Trial | |
| Australia | 2982889 | ⤷ Start Trial | |
| Australia | 614577 | ⤷ Start Trial | |
| Canada | 1322529 | FORME POSOLOGIQUE NOUVELLE DE FENOFIBRATE (DOSAGE FORM OF FENOFIBRATE) | ⤷ Start Trial |
| Germany | 68903846 | ⤷ Start Trial | |
| European Patent Office | 0330532 | NEW GALENIC FORM OF FENOFIBRATE | ⤷ Start Trial |
| Spain | 2054040 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch